Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Helsted

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMJ Open|February 27, 2023
Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trialMads M Helsted, Lærke S Gasbjerg, Tina Vilsbøll, et al.
Endocrine Connections|September 14, 2019
Gluco-metabolic effects of oral and intravenous alcohol administration in menAmalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Alcohol (Fayetteville, N.Y.)|April 27, 2020
The effect of acute intragastric vs. intravenous alcohol administration on inflammation markers, blood lipids and gallbladder motility in healthy menAmalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Bone|February 8, 2023
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetesNiels B Dalsgaard, Lærke S Gasbjerg, Mads M Helsted, et al.
The Journal of Clinical Endocrinology and Metabolism|August 29, 2025
The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetesJosefine V Hansen, David S Mathiesen, Mikkel B Christensen, et al.
Bone|July 31, 2020
The role of endogenous GIP and GLP-1 in postprandial bone homeostasisMads M Helsted, Lærke S Gasbjerg, Amalie R Lanng, et al.
Diabetes Care|October 11, 2023
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled TrialCasper K Nielsen, Caroline C Øhrstrøm, Inas J K Houji, et al.
Diabetes, Obesity & Metabolism|October 10, 2025
Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover studyLiva S L Krogh, Mads M Helsted, Anders Englund, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2020
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy IndividualsLærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trialMads M Helsted, Christiane Fonnesbech-Wulff, Nina L Schaltz, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMJ Open|February 27, 2023
Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trialMads M Helsted, Lærke S Gasbjerg, Tina Vilsbøll, et al.
Endocrine Connections|September 14, 2019
Gluco-metabolic effects of oral and intravenous alcohol administration in menAmalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Alcohol (Fayetteville, N.Y.)|April 27, 2020
The effect of acute intragastric vs. intravenous alcohol administration on inflammation markers, blood lipids and gallbladder motility in healthy menAmalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Bone|February 8, 2023
Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetesNiels B Dalsgaard, Lærke S Gasbjerg, Mads M Helsted, et al.
The Journal of Clinical Endocrinology and Metabolism|August 29, 2025
The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetesJosefine V Hansen, David S Mathiesen, Mikkel B Christensen, et al.
Bone|July 31, 2020
The role of endogenous GIP and GLP-1 in postprandial bone homeostasisMads M Helsted, Lærke S Gasbjerg, Amalie R Lanng, et al.
Diabetes Care|October 11, 2023
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled TrialCasper K Nielsen, Caroline C Øhrstrøm, Inas J K Houji, et al.
Diabetes, Obesity & Metabolism|October 10, 2025
Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover studyLiva S L Krogh, Mads M Helsted, Anders Englund, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2020
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy IndividualsLærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trialMads M Helsted, Christiane Fonnesbech-Wulff, Nina L Schaltz, et al.
Pageof 3